| Ganglioside GD3 expression on target cells can modulate NK cell cytotoxicity via siglec‐7‐dependent and‐independent mechanisms G Nicoll, T Avril, K Lock, K Furukawa, N Bovin, PR Crocker European journal of immunology 33 (6), 1642-1648, 2003 | 172 | 2003 |
| The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and-9, CD33-related Siglecs expressed on … T Avril, H Floyd, F Lopez, E Vivier, PR Crocker The Journal of Immunology 173 (11), 6841-6849, 2004 | 148 | 2004 |
| Expression of nine tumour antigens in a series of human glioblastoma multiforme: interest of EGFRvIII, IL-13Rα2, gp100 and TRP-2 for immunotherapy S Saikali, T Avril, B Collet, A Hamlat, JY Bansard, B Drenou, Y Guegan, ... Journal of neuro-oncology 81 (2), 139-148, 2007 | 124 | 2007 |
| Overview of cellular immunotherapy for patients with glioblastoma E Vauleon, T Avril, B Collet, J Mosser, V Quillien Clinical and Developmental Immunology 2010, 2010 | 112 | 2010 |
| Sialic acid-binding immunoglobulin-like lectin 7 mediates selective recognition of sialylated glycans expressed on Campylobacter jejuni lipooligosaccharides T Avril, ER Wagner, HJ Willison, PR Crocker Infection and immunity 74 (7), 4133-4141, 2006 | 112 | 2006 |
| Trophoblast cell line resistance to NK lysis mainly involves an HLA class I-independent mechanism T Avril, AC Jarousseau, H Watier, J Boucraut, P Le Bouteiller, P Bardos, ... The Journal of Immunology 162 (10), 5902-5909, 1999 | 109 | 1999 |
| Siglec-5 (CD170) can mediate inhibitory signaling in the absence of immunoreceptor tyrosine-based inhibitory motif phosphorylation T Avril, SD Freeman, H Attrill, RG Clarke, PR Crocker Journal of Biological Chemistry 280 (20), 19843-19851, 2005 | 87 | 2005 |
| Endoplasmic Reticulum Stress and the Hallmarks of Cancer H Urra, E Dufey, T Avril, E Chevet, C Hetz Trends in Cancer 2 (5), 252-262, 2016 | 81 | 2016 |
| Human Glioblastoma Stem‐Like Cells are More Sensitive to Allogeneic NK and T Cell‐Mediated Killing Compared with Serum‐Cultured Glioblastoma Cells T Avril, E Vauleon, A Hamlat, S Saikali, A Etcheverry, C Delmas, S Diabira, ... Brain Pathology 22 (2), 159-174, 2012 | 65 | 2012 |
| Probing the cis interactions of the inhibitory receptor Siglec‐7 with α2,8‐disialylated ligands on natural killer cells and other leukocytes using glycan‐specific … T Avril, SJ North, SM Haslam, HJ Willison, PR Crocker Journal of leukocyte biology 80 (4), 787-796, 2006 | 62 | 2006 |
| Distinct effects of human glioblastoma immunoregulatory molecules programmed cell death ligand-1 (PDL-1) and indoleamine 2, 3-dioxygenase (IDO) on tumour-specific T cell functions T Avril, S Saikali, E Vauléon, A Jary, A Hamlat, M De Tayrac, J Mosser, ... Journal of neuroimmunology 225 (1-2), 22-33, 2010 | 60 | 2010 |
| Differential analysis of glioblastoma multiforme proteome by a 2D-DIGE approach B Collet, N Guitton, S Saïkali, T Avril, C Pineau, A Hamlat, J Mosser, ... Proteome science 9 (1), 16, 2011 | 42 | 2011 |
| Negative regulation of leucocyte functions by CD33-related siglecs T Avril, H Attrill, J Zhang, A Raper, PR Crocker Biochemical Society Transactions 34 (6), 1024-1027, 2006 | 42 | 2006 |
| Cyclopamine cooperates with EGFR inhibition to deplete stem-like cancer cells in glioblastoma-derived spheroid cultures S Eimer, F Dugay, K Airiau, T Avril, V Quillien, MA Belaud-Rotureau, ... Neuro-Oncology, 2012 | 41 | 2012 |
| Endoplasmic reticulum proteostasis in glioblastoma—From molecular mechanisms to therapeutic perspectives J Obacz, T Avril, PJ Le Reste, H Urra, V Quillien, C Hetz, E Chevet Sci. Signal. 10 (470), eaal2323, 2017 | 38 | 2017 |
| Isolation of a new cell population in the glioblastoma microenvironment A Clavreul, A Etcheverry, A Chassevent, V Quillien, T Avril, ML Jourdan, ... Journal of neuro-oncology 106 (3), 493-504, 2012 | 35 | 2012 |
| Endoplasmic reticulum stress signaling and chemotherapy resistance in solid cancers T Avril, E Vauleon, E Chevet Oncogenesis 6 (8), e373, 2017 | 34 | 2017 |
| Glioblastoma‐associated stromal cells (GASCs) from histologically normal surgical margins have a myofibroblast phenotype and angiogenic properties A Clavreul, C Guette, R Faguer, C Tétaud, A Boissard, L Lemaire, ... The Journal of pathology 233 (1), 74-88, 2014 | 34 | 2014 |
| Mechanisms of immunomodulation in human glioblastoma T Avril, E Vauleon, S Tanguy-Royer, J Mosser, V Quillien Immunotherapy 3 (4s), 42-44, 2011 | 34 | 2011 |
| Dual IRE1 RNase functions dictate glioblastoma development S Lhomond, T Avril, N Dejeans, K Voutetakis, D Doultsinos, M McMahon, ... EMBO molecular medicine 10 (3), e7929, 2018 | 26 | 2018 |
Jean MosserUniversité de Rennes1Adresse e-mail validée de univ-rennes1.fr